Kanae Gamo

The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice

Aisha Yesbolatova, Yuichiro Saito, Naomi Kitamoto et al. · Nature Communications · 2020 · 574 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +7

A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells

Yoshinori Ishikawa, Kanae Gamo, Masato Yabuki et al. · Molecular Cancer Therapeutics · 2016 · 105 citations

Medicine, Molecular Biology, Oncology +13

Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell

Masaru Takeshita, Katsuya Suzuki, Yasushi Kondo et al. · Annals of the Rheumatic Diseases · 2019 · 92 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication

Yoshinori Ishikawa, K. Nakayama, Megumi Morimoto et al. · Oncogenesis · 2017 · 38 citations · Full text

Medicine, Molecular Biology, Oncology +16

Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesis

Masao Ōhashi, Kanae Gamo, Yuta Tanaka et al. · European Journal of Medicinal Chemistry · 2014 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13